202 related articles for article (PubMed ID: 7857690)
1. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
Hessner MJ; Roth MS; Drobyski WR; Baxter-Lowe LA
Genet Anal Tech Appl; 1994; 11(4):90-4. PubMed ID: 7857690
[TBL] [Abstract][Full Text] [Related]
2. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
Emig M; Saussele S; Wittor H; Weisser A; Reiter A; Willer A; Berger U; Hehlmann R; Cross NC; Hochhaus A
Leukemia; 1999 Nov; 13(11):1825-32. PubMed ID: 10557058
[TBL] [Abstract][Full Text] [Related]
3. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
Wells SJ; Phillips CN; Winton EF; Farhi DC
Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
[TBL] [Abstract][Full Text] [Related]
4. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
[TBL] [Abstract][Full Text] [Related]
5. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
Furukawa Y; Ju SL; Cho HL; Tatsumi N
Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
[TBL] [Abstract][Full Text] [Related]
6. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
[TBL] [Abstract][Full Text] [Related]
7. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
Leukemia; 1999 May; 13(5):818-23. PubMed ID: 10374889
[TBL] [Abstract][Full Text] [Related]
8. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
[TBL] [Abstract][Full Text] [Related]
10. Detection of Philadelphia chromosome using PCR and europium-labeled DNA probes.
Eskola JU; Hämäläinen M; Näntö V; Rajamäki A; Dahlén P; Iitiä A; Siitari H
Clin Biochem; 1994 Oct; 27(5):373-9. PubMed ID: 7867215
[TBL] [Abstract][Full Text] [Related]
11. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients.
Testoni N; Martinelli G; Farabegoli P; Zaccaria A; Amabile M; Raspadori D; Pelliconi S; Zuffa E; Carboni C; Tura S
Blood; 1996 May; 87(9):3822-7. PubMed ID: 8611708
[TBL] [Abstract][Full Text] [Related]
12. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Arocho A; Chen B; Ladanyi M; Pan Q
Diagn Mol Pathol; 2006 Mar; 15(1):56-61. PubMed ID: 16531770
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
Roth MS; Antin JH; Ash R; Terry VH; Gotlieb M; Silver SM; Ginsburg D
Blood; 1992 Jan; 79(1):276-82. PubMed ID: 1728316
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA.
Bartley PA; Ross DM; Latham S; Martin-Harris MH; Budgen B; Wilczek V; Branford S; Hughes TP; Morley AA
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e222-8. PubMed ID: 20491997
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantitation of bcr-abl transcripts in haematological malignancies.
Saffroy R; Lemoine A; Brézillon P; Frénoy N; Delmas B; Goldschmidt E; Souleau B; Nedellec G; Debuire B
Eur J Haematol; 2000 Oct; 65(4):258-66. PubMed ID: 11073166
[TBL] [Abstract][Full Text] [Related]
16. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
Huang W; Cao Q; Lu Y
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Delage R; Soiffer RJ; Dear K; Ritz J
Blood; 1991 Nov; 78(10):2759-67. PubMed ID: 1824268
[TBL] [Abstract][Full Text] [Related]
18. Rare e14a3 (b3a3) BCR-ABL fusion in chronic myeloid leukemia in India: the threats and challenges in monitoring minimal residual disease (MRD).
Vaniawala S; Acharya A; Parekh H; Mukhopadhyaya PN
Anal Cell Pathol (Amst); 2013; 36(3-4):85-92. PubMed ID: 24072036
[TBL] [Abstract][Full Text] [Related]
19. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.
Bose S; Deininger M; Gora-Tybor J; Goldman JM; Melo JV
Blood; 1998 Nov; 92(9):3362-7. PubMed ID: 9787174
[TBL] [Abstract][Full Text] [Related]
20. [Genetic diagnosis of chronic myeloid leukemia].
Kato C; Naoe T
Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]